Flávio Steinwurz

4.2k total citations · 1 hit paper
52 papers, 2.4k citations indexed

About

Flávio Steinwurz is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Flávio Steinwurz has authored 52 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Genetics, 32 papers in Epidemiology and 23 papers in Surgery. Recurrent topics in Flávio Steinwurz's work include Inflammatory Bowel Disease (45 papers), Microscopic Colitis (28 papers) and Eosinophilic Esophagitis (12 papers). Flávio Steinwurz is often cited by papers focused on Inflammatory Bowel Disease (45 papers), Microscopic Colitis (28 papers) and Eosinophilic Esophagitis (12 papers). Flávio Steinwurz collaborates with scholars based in Brazil, United States and Canada. Flávio Steinwurz's co-authors include Richard B. Gearry, Jean‐Frédéric Colombel, Walter Reinisch, Siew C. Ng, Ryan C. Ungaro, Jean‐François Rahier, Gilaad G. Kaplan, James D. Lewis, Erica J. Brenner and Michele Kissous-Hunt and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Gut.

In The Last Decade

Flávio Steinwurz

47 papers receiving 2.4k citations

Hit Papers

Corticosteroids, But Not TNF Antagonists, Are Associated ... 2020 2026 2022 2024 2020 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry
    2020 454 citations Erica J. Brenner, Ryan C. Ungaro et al. Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Flávio Steinwurz Brazil 17 1.4k 950 635 541 534 52 2.4k
Jean‐François Rahier Belgium 21 741 0.5× 581 0.6× 614 1.0× 344 0.6× 394 0.7× 60 2.0k
Parakkal Deepak United States 27 1.4k 1.0× 1.1k 1.1× 248 0.4× 832 1.5× 397 0.7× 209 2.5k
Manasi Agrawal United States 24 1.1k 0.8× 751 0.8× 385 0.6× 466 0.9× 233 0.4× 104 2.0k
Federica Furfaro Italy 26 1.5k 1.1× 1.1k 1.1× 240 0.4× 644 1.2× 315 0.6× 151 2.2k
Mariangela Allocca Italy 33 2.0k 1.5× 1.6k 1.7× 271 0.4× 1.1k 1.9× 453 0.8× 177 3.3k
Amar R. Deshpande United States 22 1.2k 0.9× 973 1.0× 182 0.3× 549 1.0× 321 0.6× 93 2.2k
Julien Kirchgesner France 21 1.2k 0.9× 923 1.0× 260 0.4× 506 0.9× 342 0.6× 59 1.9k
Miguel Regueiro United States 25 2.4k 1.8× 1.8k 1.9× 220 0.3× 1.3k 2.4× 416 0.8× 184 3.4k
Frank Anderson Canada 23 1.5k 1.1× 2.3k 2.4× 361 0.6× 969 1.8× 480 0.9× 64 3.7k
Ben Kang South Korea 23 657 0.5× 526 0.6× 196 0.3× 353 0.7× 273 0.5× 111 1.8k

Countries citing papers authored by Flávio Steinwurz

Since Specialization
Citations

This map shows the geographic impact of Flávio Steinwurz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Flávio Steinwurz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Flávio Steinwurz more than expected).

Fields of papers citing papers by Flávio Steinwurz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Flávio Steinwurz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Flávio Steinwurz. The network helps show where Flávio Steinwurz may publish in the future.

Co-authorship network of co-authors of Flávio Steinwurz

This figure shows the co-authorship network connecting the top 25 collaborators of Flávio Steinwurz. A scholar is included among the top collaborators of Flávio Steinwurz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Flávio Steinwurz. Flávio Steinwurz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hart, A, Flávio Steinwurz, Silvio Danese, et al.. (2025). OP33 Efficacy and safety of subcutaneous guselkumab induction therapy in patients with moderately to severely active Crohn’s disease: Results through Week 48 from the phase 3 GRAVITI study. Journal of Crohn s and Colitis. 19(Supplement_1). i66–i67. 1 indexed citations
2.
Steinwurz, Flávio, Silvio Danese, Tadakazu Hisamatsu, et al.. (2025). Efficacy and Safety of Guselkumab Subcutaneous Induction and Maintenance in Participants With Moderately to Severely Active Crohn’s Disease: Results From the Phase 3 GRAVITI Study. Gastroenterology. 169(2). 308–325. 12 indexed citations
3.
Regueiro, Miguel, Britta Siegmund, Andrés Yarur, et al.. (2024). Etrasimod for the Treatment of Ulcerative Colitis: Analysis of Infection Events from the ELEVATE UC Clinical Programme. Journal of Crohn s and Colitis. 18(10). 1596–1605. 6 indexed citations
4.
Steinwurz, Flávio, Silvio Danese, Tadakazu Hisamatsu, et al.. (2024). S1052 Efficacy and Safety of Subcutaneous Guselkumab Induction Therapy in Patients With Moderately to Severely Active Crohn’s Disease: Results Through Week 48 From the Phase 3 GRAVITI Study. The American Journal of Gastroenterology. 119(10S). S740–S741. 8 indexed citations
5.
Kaplan, Gilaad G., Fox E. Underwood, Stephanie Coward, et al.. (2022). The Multiple Waves of COVID-19 in Patients With Inflammatory Bowel Disease: A Temporal Trend Analysis. Inflammatory Bowel Diseases. 28(11). 1687–1695. 3 indexed citations
6.
Parra, Rogério Serafim, Júlio Maria Fonseca Chebli, Natália Sousa Freitas Queiroz, et al.. (2022). Long-term effectiveness and safety of ustekinumab in bio-naïve and bio-experienced anti-tumor necrosis factor patients with Crohn’s disease: a real-world multicenter Brazilian study. BMC Gastroenterology. 22(1). 199–199. 15 indexed citations
7.
Ungaro, Ryan C., Erica J. Brenner, Manasi Agrawal, et al.. (2021). Impact of Medications on COVID-19 Outcomes in Inflammatory Bowel Disease: Analysis of More Than 6000 Patients From an International Registry. Gastroenterology. 162(1). 316–319.e5. 34 indexed citations
8.
Yamamoto‐Furusho, Jesús K., Francisco Bosques‐Padilla, Juan De Paula, et al.. (2021). Latin American consensus on the quality indicators for comprehensive care clinics for patients with inflammatory bowel disease: PANCCO-GETECCU. SHILAP Revista de lepidopterología. 87(1). 89–102. 3 indexed citations
9.
Gearry, Richard B., Andrew McCombie, Morten Vatn, et al.. (2021). What Are the Most Challenging Aspects of Inflammatory Bowel Disease? An International Survey of Gastroenterologists Comparing Developed and Developing Countries. Inflammatory Intestinal Diseases. 6(2). 78–86. 5 indexed citations
10.
Ungaro, Ryan C., Erica J. Brenner, Richard B. Gearry, et al.. (2020). Effect of IBD medications on COVID-19 outcomes: results from an international registry. Gut. 70(4). 725–732. 178 indexed citations
11.
Brenner, Erica J., Ryan C. Ungaro, Richard B. Gearry, et al.. (2020). Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry. Gastroenterology. 159(2). 481–491.e3. 454 indexed citations breakdown →
12.
Kotze, Paulo Gustavo, Flávio Steinwurz, Carlos Fernando de Magalhães Francisconi, et al.. (2020). Review of the epidemiology and burden of ulcerative colitis in Latin America. Therapeutic Advances in Gastroenterology. 13. 3974120603–3974120603. 30 indexed citations
13.
Sandborn, William J., Bruce E. Sands, Flávio Steinwurz, et al.. (2020). P113 EVALUATION OF THE EFFICACY OF TOFACITINIB IN PATIENTS WITH ULCERATIVE COLITIS UTILIZING THE MODIFIED MAYO SCORE: DATA FROM THE OCTAVE PROGRAM. Inflammatory Bowel Diseases. 26(Supplement_1). S17–S18. 1 indexed citations
14.
Gearry, Richard B., Andrew McCombie, Morten H. Vatn, et al.. (2019). Tu1813 – What are the Most Challenging Aspects of Ibd? - an International Survey of Gastroenterologists Comparing Western and Non-Western Countries. Gastroenterology. 156(6). S–1134. 1 indexed citations
15.
Yamamoto‐Furusho, Jesús K., Francisco Bosques‐Padilla, Juan A. De Paula, et al.. (2017). Situaciones especiales en la enfermedad inflamatoria intestinal: primer consenso latinoamericano de la Pan American Crohn's and Colitis Organisation (PANCCO) (Segunda parte). Revista de Gastroenterología de México. 82(2). 134–155. 1 indexed citations
16.
Yamamoto‐Furusho, Jesús K., Francisco Bosques‐Padilla, Juliana DePaula, et al.. (2017). Diagnosis and treatment of inflammatory bowel disease: First Latin American Consensus of the Pan American Crohn's and Colitis Organisation. SHILAP Revista de lepidopterología. 82(1). 46–84. 25 indexed citations
17.
Bernstein, Çharles N., Abraham R. Eliakim, S S Fedail, et al.. (2016). World Gastroenterology Organisation Global Guidelines Inflammatory Bowel Disease. Journal of Clinical Gastroenterology. 50(10). 803–818. 154 indexed citations
18.
Yamamoto‐Furusho, Jesús K., Francisco Bosques‐Padilla, Juliana DePaula, et al.. (2016). Diagnóstico y tratamiento de la enfermedad inflamatoria intestinal: Primer Consenso Latinoamericano de la Pan American Crohn's and Colitis Organisation. Revista de Gastroenterología de México. 82(1). 46–84. 24 indexed citations
19.
Papay, Pavol, Ana Ignjatovic, Konstantinos Κarmiris, et al.. (2013). Optimising monitoring in the management of Crohn's disease: A physician's perspective. Journal of Crohn s and Colitis. 7(8). 653–669. 85 indexed citations
20.
Mahadevan, Uma, Salvatore Cucchiara, Jeffrey S. Hyams, et al.. (2010). The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organisation: Pregnancy and Pediatrics. The American Journal of Gastroenterology. 106(2). 214–223. 153 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐François Rahier Breakdown of academic impact, for papers by Parakkal Deepak Breakdown of academic impact, for papers by Manasi Agrawal Breakdown of academic impact, for papers by Federica Furfaro Breakdown of academic impact, for papers by Mariangela Allocca Breakdown of academic impact, for papers by Amar R. Deshpande Breakdown of academic impact, for papers by Julien Kirchgesner Breakdown of academic impact, for papers by Miguel Regueiro Breakdown of academic impact, for papers by Frank Anderson Breakdown of academic impact, for papers by Ben Kang
Rankless by CCL
2026